Reports Q1 sales EUR13.02B vs. EUR9.14B last year. Reports Q1 adjusted EBITDA EUR4.19B vs. EUR2.896B last year. Crop Science posted a 5.5% sales increase to EURO$6,444 million, which came primarily from the Latin and North America regions. Reported sales of Crop Science were up by 125.2%, mainly because of a 119.5% portfolio effect. Pharmaceuticals registered encouraging sales growth of 5.3% to EURO$4,354 million, with business in China developing particularly well. Sales of Consumer Health declined by 1.4% to EURO$1,395 million, chiefly as a result of the negative development in the Europe / Middle East/Africa region. Animal Health recorded sales of EURO$421 million, level with the prior-year quarter.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.